People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NeuroPace Inc | — | Other Health Care | Series C | $208.6M | $1.5B | 2011 |
| ShiraTronics, Inc | — | Biotechnology | Series C | $79.1M | $307.2M | 2019 |
| Hyalex Orthopaedics, Inc. | — | Other Health Care | Series B | $30.4M | $91.1M | 2024 |
| AgilVax, Inc. | — | Biotechnology | Seed | $4.2M | $133.2M | 2018 |
Brad Vale at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brad Vale on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Renee Ryan | 2 | 6 |
| Wende Hutton | 1 | 16 |
| Casey Tansey | 1 | 14 |
| Rishi Gupta | 1 | 12 |
| Nael Kassar | 1 | 11 |
| Jonathan Silverstein | 1 | 10 |
| Greg Garfield | 1 | 8 |
| Brian Birk | 1 | 8 |
| James Blair | 1 | 8 |
| Joyce Erony | 1 | 8 |
| Ebetuel Pallares | 1 | 7 |
| David Fischell | 1 | 6 |
| Waneta Tuttle | 1 | 6 |
| Benjamin Pless | 1 | 5 |
| V. Kadir Kadhiresan | 1 | 5 |
| Frank Fischer | 1 | 5 |
| Mudit Jain | 1 | 4 |
| Evan Norton | 1 | 4 |
| Waneta C. Tuttle | 1 | 4 |
| Stuart Rose | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.